These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease. Wilder RB; Schlembach PJ; Jones D; Chronowski GM; Ha CS; Younes A; Hagemeister FB; Barista I; Cabanillas F; Cox JD Cancer; 2002 Mar; 94(6):1731-8. PubMed ID: 11920535 [TBL] [Abstract][Full Text] [Related]
26. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study. Salloum E; Doria R; Farber LR; Roberts KB; Cooper DL Cancer J Sci Am; 1995; 1(4):267-73. PubMed ID: 9166487 [TBL] [Abstract][Full Text] [Related]
27. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease. Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727 [TBL] [Abstract][Full Text] [Related]
28. Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease: seven-year results of a prospective randomized trial. Longo DL; Glatstein E; Duffey PL; Young RC; Hubbard SM; Urba WJ; Wesley MN; Raubitschek A; Jaffe ES; Wiernik PH J Clin Oncol; 1991 Jun; 9(6):906-17. PubMed ID: 2033427 [TBL] [Abstract][Full Text] [Related]
29. Treatment of pediatric Hodgkin disease avoiding radiotherapy: excellent outcome with the Rotterdam-HD-84-protocol. Hakvoort-Cammel FG; Buitendijk S; van den Heuvel-Eibrink M; Hählen K Pediatr Blood Cancer; 2004 Jul; 43(1):8-16. PubMed ID: 15170884 [TBL] [Abstract][Full Text] [Related]
30. ABVD and radiation therapy as first-line treatment in advanced Hodgkin's disease. Zinzani PL; Magagnoli M; Frezza G; Barbieri E; Gherlinzoni F; Galuppi A; Bendandi M; Merla E; Albertini P; Babini L; Tura S Leuk Lymphoma; 1999 Feb; 32(5-6):553-9. PubMed ID: 10048428 [TBL] [Abstract][Full Text] [Related]
31. Combinaed chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for patients with advanced Hodgkin's disease. An alternative program to MOPP. Bloomfield CD; Weiss RB; Fortuny I; Vosika G; Kennedy BJ Cancer; 1976 Jul; 38(1):42-8. PubMed ID: 947533 [TBL] [Abstract][Full Text] [Related]
32. Extended-field radiotherapy in favorable stage IA-IIA Hodgkin's disease (prognostic role of stage). Zanini M; Viviani S; Santoro A; Soncini F; Bonfante V; Devizzi L; Villani F; Castellani MR; Negretti E; Zucali R Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):813-9. PubMed ID: 7525516 [TBL] [Abstract][Full Text] [Related]
34. Vancouver hybrid: preliminary experience in the treatment of Hodgkin's disease in childhood and adolescence. Khan SP; Gilchrist GS; Arndt CA; Smithson WA; Chen MG; Schomberg PJ; Matsumoto JM; O'Fallon WM Mayo Clin Proc; 1994 Oct; 69(10):949-54. PubMed ID: 7523802 [TBL] [Abstract][Full Text] [Related]
35. Combination chemotherapy for stage IV Hodgkin's disease (Report no 14). Goldman JM Clin Radiol; 1981 Sep; 32(5):531-6. PubMed ID: 6168426 [TBL] [Abstract][Full Text] [Related]
36. Comparison of total nodal irradiation versus combined sequence of mantle irradiation with mechlorethamine, vincristine, procarbazine, and prednisone in clinical stages I and II Hodgkin's disease: experience of the European Organization for Research and Treatment of Cancer. Carde P; Hayat M; Cosset JM; Somers R; Burgers JM; Sizoo W; Meerwaldt JH; Hagenbeek A; Monconduit M; van der Schueren E NCI Monogr; 1988; (6):303-10. PubMed ID: 3352775 [TBL] [Abstract][Full Text] [Related]
37. Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP. Bonadonna G; Zucali R; Monfardini S; De Lena M; Uslenghi C Cancer; 1975 Jul; 36(1):252-9. PubMed ID: 54209 [TBL] [Abstract][Full Text] [Related]
38. Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease. Piga A; Ambrosetti A; Todeschini G; Cetto G; Perona G; Cellerino R Cancer Treat Rep; 1984; 68(7-8):947-51. PubMed ID: 6204754 [TBL] [Abstract][Full Text] [Related]
39. Second malignant tumours in childhood Hodgkin's disease. Jenkin D; Greenberg M; Fitzgerald A Med Pediatr Oncol; 1996 Jun; 26(6):373-9. PubMed ID: 8614372 [TBL] [Abstract][Full Text] [Related]
40. Early-stage Hodgkin's disease: long-term results with radiotherapy alone or combined radiotherapy and chemotherapy. Brusamolino E; Lazzarino M; Orlandi E; Canevari A; Morra E; Castelli G; Alessandrino EP; Pagnucco G; Astori C; Livraghi A Ann Oncol; 1994; 5 Suppl 2():101-6. PubMed ID: 7515642 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]